ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

Comparability of PT Determination with STA-NeoPTimal on STart and STart Max Semi-automated Instruments

G. Le Goff1, M. Bouchain1, A. Carlo2, J. Beltran1

1Diagnostica Stago, Gennevilliers, France, 2Diagnostica Stago, Asnières-sur-Seine, France

Abstract Number: PB0379

Meeting: ISTH 2021 Congress

Theme: Diagnostics and OMICs » Laboratory Diagnostics

Background: Prothrombin time (PT) is a cornerstone of the routine hemostasis panel. This means the test has to be available any time, in any laboratory, whatever the test platform. Quality management plans within clinical laboratories verify this consistency, but to ease this work, manufacturers can show the agreement by design.

Aims: The objective of this study was to show the correlation and agreement of PT/INR determination with STA-NeoPTimal when assessed on STart and STart Max semi-automated analyzers.

Methods: 86 individual samples, spreading the PT measuring range, were tested with one batch of STA-NeoPTimal on STart and STart Max analyzer in parallel (reagents and analyzers from Stago, Asnières-sur-Seine, France). This samples set included samples from patients under vitamin K antagonists or patients having any exogenous factor deficiency.
The ISI used for INR determination was the one provided by the manufacturer while the mean normal prothrombin time (MNPT) was the one determined locally.

Results: Linear regression was performed to evaluate correlations. Slope, intercept and Pearson correlation coefficients of those regressions are displayed in table 1.

STart vs STart Max Linear regression equation
y = ax+b
Pearson correlation coefficient (r) Average bias
Slope (a) Intercept (b)
PT (sec) 1.01 -0.58 0.995 1%
INR 1.01 -0.04 0.996 -0.89% to 01% depending on INR levels

Conclusions: Results confirm a very high correlation and agreement of PT/INR determination with STA-NeoPTimal in its semi-automated methodology on both STart and STart Max instruments. These good results preclude easy method validation process and assay flexibility, for a possible instrument switch over time.

To cite this abstract in AMA style:

Le Goff G, Bouchain M, Carlo A, Beltran J. Comparability of PT Determination with STA-NeoPTimal on STart and STart Max Semi-automated Instruments [abstract]. Res Pract Thromb Haemost. 2021; 5 (Suppl 2). https://abstracts.isth.org/abstract/comparability-of-pt-determination-with-sta-neoptimal-on-start-and-start-max-semi-automated-instruments/. Accessed May 16, 2022.

« Back to ISTH 2021 Congress

ISTH Congress Abstracts - https://abstracts.isth.org/abstract/comparability-of-pt-determination-with-sta-neoptimal-on-start-and-start-max-semi-automated-instruments/

Simple Search

Supported By:

Bristol Myers Squibb and Pfizer

ISTH 2021 Congress site

Visit the official web site for the ISTH 2021 Virtual Congress »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley